Annual Drug Patent Expirations for AYVAKIT Ayvakit is a drug marketed by Blueprint Medicines and is included in one NDA. It is available from one supplier. There are four patents…
Source
Annual Drug Patent Expirations for NEXLIZET Nexlizet is a drug marketed by Esperion Theraps Inc and is included in one NDA. It is available from one supplier. There are five…
Source
Annual Drug Patent Expirations for PROBUPHINE Probuphine is a drug marketed by Titan Pharms and is included in one NDA. There is one patent protecting this drug. This drug has…
Source
New patent expiration for Titan Pharms drug PROBUPHINE Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
New tentative approval for Xiamen Lp drug topiramate Read Post »
This chart shows the pharmaceutical companies with the most supplementary protection certificates (SPCs) in Romania. SPCs are used in European Union and select others to encourage pharmaceutical innovation by compensating…
Source
Which pharmaceutical companies have the most SPCs in Romania? Read Post »
[](//www.DrugPatentWatch.com/p/preview/generic-api/topiramate?utm_medium=dpw_wp_blog&utm_campaign=dpw_wp_blog&utm_source=dpw_wp_blog) Topiramate is the generic in…
New tentative approval for Xiamen Lp drug topiramate Read Post »
Annual Drug Patent Expirations for ADZENYS+XR-ODT Adzenys Xr-odt is a drug marketed by Neos Theraps and is included in one NDA. It is available from one supplier. There are four…
Source
This chart shows the pharmaceutical companies with the most lotion dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most lotion dosed drugs…
Source
Which pharmaceutical companies have the most lotion dosed drugs? Read Post »
Drug repurposing, or identifying new therapeutic uses for existing drugs, is gaining significant momentum as a promising approach to accelerate drug development and reduce costs. This book chapter provides a…
Source
SOOLANTRA (ivermectin) Galderma labs lp Patent: 7,550,440 Expiration: Apr 22, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
Source
Drug Patent Expirations for the Week of April 21, 2024 Read Post »
Get new actionable insights and updates from BiotechBlog
